Surgery for malignant obstructive jaundice: analysis of mortality

Area of Science:

• Hepatobiliary Surgery
• Surgical Oncology
• Gastroenterology

Background:

• Malignant obstructive jaundice presents significant surgical risks.
• High serum bilirubin levels (>100 mumol/L) complicate patient management.
• Retrospective analysis of 120 patients informs surgical strategies.

Purpose of the Study:

• To identify risk factors for mortality in patients undergoing surgery for malignant obstructive jaundice.
• To establish guidelines for improved perioperative management.
• To validate predictive models for high-risk surgical patients.

Main Methods:

• Retrospective analysis of 120 patients with obstructive jaundice (bilirubin >100 mumol/L).
• Multivariate analysis of clinical, laboratory, and operative parameters to identify mortality risk factors.
• Validation of identified risk factors in a separate patient cohort.

Main Results:

• 35% of patients experienced complications, with a 26.7% in-hospital mortality rate.
• Key predictors of mortality included age >65, AST >90 IU, and urea >7 mmol/L.
• Elevated urea and AST correlated with the need for urgent surgery.

Conclusions:

• Age, AST, and urea levels are significant predictors of mortality in obstructive jaundice surgery.
• Aggressive nonoperative management is recommended for emergent cases.
• Consideration of alternative therapies or perioperative strategies for high-risk patients is crucial before definitive surgery.